FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance
Authors:
- 1 June 2000
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 52 (6) , 749-757
Abstract
OBJECTIVE The chromosomal regions containing the two putative tumour suppressors, fragile histidine triad gene (FHIT) and tumour suppressor gene 101 (TSG101), are deleted frequently in thyroid tumou...Keywords
This publication has 14 references indexed in Scilit:
- Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumoursOncogene, 1997
- Chromosome 3p14 Homozygous Deletions and Sequence Analysis of FRA3BHuman Molecular Genetics, 1997
- tsg101: A Novel Tumor Susceptibility Gene Isolated by Controlled Homozygous Functional Knockout of Allelic Loci in Mammalian CellsCell, 1996
- Native Polyacrylamide Gel Electrophoresis1996
- Agarose Gel Electrophoresis1995
- Accurate and absolute quantitative measurement of gene expression by single-tube RT-PCR and HPLC.Genome Research, 1995
- Alteration of tumorigenicity in undifferentiated thyroid carcinoma cells by introduction of normal chromosome 11Journal of Surgical Oncology, 1994
- Antioncogenes and human cancer.Proceedings of the National Academy of Sciences, 1993
- Allelotype of Human Thyroid Tumors: Loss of Chromosome 11q13 Sequences in Follicular NeoplasmsMolecular Endocrinology, 1991
- Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytesCancer Genetics and Cytogenetics, 1988